Healthcare provider profile · identity verified

Benedict J Farino, MD

Internal Medicine · SCARBOROUGH, ME · NPI 1104912864

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	842	245
Losartan Potassium	Losartan Potassium	437	129
Lisinopril	Lisinopril	420	115
Amlodipine Besylate	Amlodipine Besylate	412	127
Levothyroxine Sodium	Levothyroxine Sodium	397	113
Omeprazole	Omeprazole	359	108
Rosuvastatin Calcium	Rosuvastatin Calcium	297	100
Hydrochlorothiazide	Hydrochlorothiazide	284	86
Metoprolol Succinate	Metoprolol Succinate	279	87
Sertraline Hcl	Sertraline Hcl	169	44
Eliquis	Apixaban	163	42
Simvastatin	Simvastatin	139	38
Tamsulosin Hcl	Tamsulosin Hcl	125	39
Gabapentin	Gabapentin	121	31
Alendronate Sodium	Alendronate Sodium	116	36
Ozempic	Semaglutide	111	23
Lorazepam	Lorazepam	110	28
Furosemide	Furosemide	109	37
Metformin Hcl	Metformin Hcl	100	31
Metformin Hcl Er	Metformin Hcl	98	33
Jardiance	Empagliflozin	91	28
Pantoprazole Sodium	Pantoprazole Sodium	88	28
Duloxetine Hcl	Duloxetine Hcl	83	24
Carvedilol	Carvedilol	78	19
Zolpidem Tartrate	Zolpidem Tartrate	76	20
Albuterol Sulfate Hfa	Albuterol Sulfate	75	37
Trazodone Hcl	Trazodone Hcl	75	31
Allopurinol	Allopurinol	74	19
Fluoxetine Hcl	Fluoxetine Hcl	66	23
Pravastatin Sodium	Pravastatin Sodium	66	22
Xarelto	Rivaroxaban	65	20
Metoprolol Tartrate	Metoprolol Tartrate	62	21
Atenolol	Atenolol	59	20
Escitalopram Oxalate	Escitalopram Oxalate	56	17
Mirtazapine	Mirtazapine	56	20
Bupropion Xl	Bupropion Hcl	55	14
Famotidine	Famotidine	55	14
Fluticasone Propionate	Fluticasone Propionate	55	22
Glipizide	Glipizide	55	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Clonazepam	Clonazepam	49	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	16
Buspirone Hcl	Buspirone Hcl	47	suppressed
Ezetimibe	Ezetimibe	47	15
Pregabalin	Pregabalin	46	17
Chlorthalidone	Chlorthalidone	44	14
Spironolactone	Spironolactone	44	17
Finasteride	Finasteride	41	14
Tramadol Hcl	Tramadol Hcl	41	12
Montelukast Sodium	Montelukast Sodium	40	12
Citalopram Hbr	Citalopram Hydrobromide	38	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	37	37
Synthroid	Levothyroxine Sodium	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Prednisone	Prednisone	33	21
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Alprazolam	Alprazolam	30	13
Oxycodone Hcl	Oxycodone Hcl	30	11
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Clonidine Hcl	Clonidine Hcl	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	12
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	13
Diazepam	Diazepam	23	12
Donepezil Hcl	Donepezil Hcl	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Nitroglycerin	Nitroglycerin	21	14
Dilt-Xr	Diltiazem Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	14
Torsemide	Torsemide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Felodipine Er	Felodipine	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Amoxicillin	Amoxicillin	16	11
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Linzess	Linaclotide	15	suppressed
Methylprednisolone	Methylprednisolone	15	11
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Myrbetriq	Mirabegron	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Valsartan	Valsartan	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Risperidone	Risperidone	12	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error